Ed Trappler has dedicated his professional career to the study, implementation and advancement of the science and technology of lyophilization. In 1992, he founded Lyophilization Technology, Inc. to continue his aspiration of establishing a source of scientific and technical services while expanding the knowledge and understanding of lyophilization within the industry. He is actively involved in Business Development, the Scientific Advisory Board, and Marketing.
Ed has over 40 years' experience in lyophilization that ranges from product development to equipment application engineering. His experience in the pharmaceutical industry includes product development, toxicology supply preparation, clinical manufacturing, and parenteral production. Prior to founding the company, he served as a Systems Application Engineer for Hull Corporation. Ed received his Bachelor of Science degree in Chemistry from The College of New Jersey.
Active in promoting lyophilization in the health care industry, Ed has contributed chapters to six books and authored and presented numerous papers and courses in freeze drying across the North American, European and Asian continents. He has received numerous recognitions for contributions to the industry. He is an active member of the PDA, serving on a number of committees, including as chairperson of the Lyophilization Interest Group and Validation Task Force. The PDA awarded him the Gordon Personeous award for his long term contributions to the PDA and the James Agalloco award for his contribution to education. He is also a member of the AIChE, and has been active in and presents for the AAPS, ISPE, and ISL-FD.
Carrie Shults, Associate Director of Development Sciences, oversees the Development and Process Laboratories and is also involved in directing and overseeing client projects. She is responsible for scientific, technical, and quality oversight of all development activities. She is also a member of the marketing team.
Carrie has more than 20 years of professional experience in academia and industry. She began her career in the molecular biology field of pulmonary medicine as a research scientist. Prior to joining LTI she held positions at Merck and GlaxoSmithKline.
Carrie received a Bachelor of Science degree in Biology from Neumann University and her Master of Science degree in Clinical Research from Drexel University. She has been published in the Journal of Clinical Investigation, Journal of Allergy and Clinical Immunology, and American Journal of Physiology, and has authored and presented abstracts and poster presentations for society meetings. Carrie is a member of AAPS, ACS, ISL-FD, and PDA.
Christine Adams serves as Business Operations Manager and the Marketing and Communications Director. She oversees all aspects of LTI business operations, including finance, human resources, information technology, and heads Marketing and Corporate Communications.
Chris has more than 22 years of professional experience in a variety of business and administrative roles. Her diverse experience includes accounting, office administration, marketing, human resources, and information technology. Prior to joining LTI, she was Office Manager and Assistant to the President of Certified Video Productions/Certified Medical Illustrations.
Chris completed coursework at Bucks County Community College in areas of Accounting, Computer Science, and Designing and Publishing for the World Wide Web. She is a member of the MidAtlantic Employers' Association.
Rick joined LTI as the Manager of Clinical Manufacturing in January 2017 and is excited to be a part of the team. He is responsible for working with and providing guidance to manufacturing staff and support to Project Directors and Quality Assurance for the production of Toxicology, Phase I and Phase II Clinical Trial Materials. Rick attended DeSales University where he obtained his Bachelor's on Business Management. Rick furthered his education in the Masters of Business Management and Leadership program at Capella University. Rick has more than 20 years in various management positions where he honed his skills in training and process improvement. During his most recent tenure at Merck, West Point, he oversaw bulk manufacturing of Varicella vaccine.